Calsada Crispina
Chief Financial Officer at Regulus Therapeutics Inc.
- Sold, on record
- $62k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 14, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Regulus Therapeutics Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Regulus Therapeutics Inc.UnusualJan 18, 2024 2024
Sold 5,468 shares at $1.19 ($7k)
Calsada Crispina, Chief Financial Officer
No 10b5-1 planSold 48.6% of holdings ($13k position)5,782 shares leftFirst sale on recordFiling
- 2 Form 4 sale Regulus Therapeutics Inc.RoutineJan 14, 2025 +362 days
Sold 43,804 shares at $1.26 ($55k)
Calsada Crispina, Chief Financial Officer
10b5-1 planSold 49.1% of holdings ($112k position)45,478 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2025 | Jan 15, 2025 | Regulus Therapeutics Inc. | Chief Financial Officer | Form 4 sale | 43,804 | $55k | 49.1% | Routine | SEC |
| Jan 18, 2024 | Jan 18, 2024 | Regulus Therapeutics Inc. | Chief Financial Officer | Form 4 sale | 5,468 | $7k | 48.6% | Unusual | SEC |